Enhanced PI3K p110alpha signaling confers acquired lapatinib resistance that can be effectively reversed by a p110alpha-selective PI3K inhibitor.

Brady SW, Zhang J, Seok D, Wang H, Yu D
Mol Cancer Ther. 2014 Jan;13(1):60-70. doi: 10.1158/1535-7163.MCT-13-0518. Epub 2013 Nov 18. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.